Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ashkaan Younai

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
The Journal of Organic Chemistry|November 11, 2010
Diastereoselective synthesis of (±)-heliotropamide by a one-pot, four-component reactionAshkaan Younai, Gregory F Chin, Jared T Shaw
Current Opinion in Chemical Biology|April 16, 2010
Recent advances in multicomponent reactions for diversity-oriented synthesisJames E Biggs-Houck, Ashkaan Younai, Jared T Shaw
Angewandte Chemie (International Ed. in English)|April 28, 2015
Enantioselective Syntheses of Heteroyohimbine Natural Products: A Unified Approach through Cooperative CatalysisAshkaan Younai, Bi-Shun Zeng, Herbert Y Meltzer, et al.
Journal of the American Chemical Society|July 15, 2014
Enantioselective annulations for dihydroquinolones by in situ generation of azolium enolatesAnna Lee, Ashkaan Younai, Christopher K Price, et al.
Organic Letters|September 28, 2013
Stereoselective synthesis of γ-lactams from imines and cyanosuccinic anhydridesDarlene Q Tan, Ashkaan Younai, Ommidala Pattawong, et al.
Journal of Medicinal Chemistry|January 23, 2026
Discovery and Characterization of Zelnecirnon (RPT193), a Potent and Selective CCR4 Antagonist for Allergic DisordersMikhail Zibinsky, Delia Bradford, Dirk G Brockstedt, et al.
Journal of Medicinal Chemistry|July 16, 2020
Novel Piperidinyl-Azetidines as Potent and Selective CCR4 Antagonists Elicit Antitumor Response as a Single Agent and in Combination with Checkpoint InhibitorsOmar Robles, Jeffrey J Jackson, Lisa Marshall, et al.
Journal of Medicinal Chemistry|July 2, 2019
Discovery of a Potent and Selective CCR4 Antagonist That Inhibits T<sub>reg</sub> Trafficking into the Tumor MicroenvironmentJeffrey J Jackson, John M Ketcham, Ashkaan Younai, et al.
Journal of Medicinal Chemistry|July 14, 2026
Discovery of Tivumecirnon (FLX475), a Potent and Selective CCR4 Antagonist That Inhibits the Migration of Immunosuppressive Regulatory T Cells into the Tumor Microenvironment to Restore Antitumor ImmunityOmar Robles, Dirk G Brockstedt, Joel Aponte-Guzman, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
The Journal of Organic Chemistry|November 11, 2010
Diastereoselective synthesis of (±)-heliotropamide by a one-pot, four-component reactionAshkaan Younai, Gregory F Chin, Jared T Shaw
Current Opinion in Chemical Biology|April 16, 2010
Recent advances in multicomponent reactions for diversity-oriented synthesisJames E Biggs-Houck, Ashkaan Younai, Jared T Shaw
Angewandte Chemie (International Ed. in English)|April 28, 2015
Enantioselective Syntheses of Heteroyohimbine Natural Products: A Unified Approach through Cooperative CatalysisAshkaan Younai, Bi-Shun Zeng, Herbert Y Meltzer, et al.
Journal of the American Chemical Society|July 15, 2014
Enantioselective annulations for dihydroquinolones by in situ generation of azolium enolatesAnna Lee, Ashkaan Younai, Christopher K Price, et al.
Organic Letters|September 28, 2013
Stereoselective synthesis of γ-lactams from imines and cyanosuccinic anhydridesDarlene Q Tan, Ashkaan Younai, Ommidala Pattawong, et al.
Journal of Medicinal Chemistry|January 23, 2026
Discovery and Characterization of Zelnecirnon (RPT193), a Potent and Selective CCR4 Antagonist for Allergic DisordersMikhail Zibinsky, Delia Bradford, Dirk G Brockstedt, et al.
Journal of Medicinal Chemistry|July 16, 2020
Novel Piperidinyl-Azetidines as Potent and Selective CCR4 Antagonists Elicit Antitumor Response as a Single Agent and in Combination with Checkpoint InhibitorsOmar Robles, Jeffrey J Jackson, Lisa Marshall, et al.
Journal of Medicinal Chemistry|July 2, 2019
Discovery of a Potent and Selective CCR4 Antagonist That Inhibits T<sub>reg</sub> Trafficking into the Tumor MicroenvironmentJeffrey J Jackson, John M Ketcham, Ashkaan Younai, et al.
Journal of Medicinal Chemistry|July 14, 2026
Discovery of Tivumecirnon (FLX475), a Potent and Selective CCR4 Antagonist That Inhibits the Migration of Immunosuppressive Regulatory T Cells into the Tumor Microenvironment to Restore Antitumor ImmunityOmar Robles, Dirk G Brockstedt, Joel Aponte-Guzman, et al.
Pageof 1